Replies to post #87352 on Biotech Values

[DewDiligence]

Any thoughts on investing in the needle-free vaccine delivery? How much does this news help these three companies?

If you want to participate to a material degree in the upside from this technology, you can’t do it by owning GSK or NVS. You have to buy Intercell, which trades on the Vienna exchange.